Latest Cost Control News

Page 2 of 88
EZZ Life Science cut its quarterly operating cash outflow sharply despite a 37.7% drop in customer receipts, as weaker Chinese e-commerce sales continued to weigh. EAORON skincare growth and a $9.16 million cash balance offer some support, but distributor collections and potential product returns remain unresolved.
Victor Sage
Victor Sage
30 Oct 2026
I Synergy ended the September quarter with A$44,000 in cash and an estimated 0.76 quarters of funding, before securing A$200,000 in loan funding after quarter-end. Its proposed Macau digital economy partnership remains non-binding, while a prior half-year review flagged material uncertainty around going concern.
Sophie Babbage
Sophie Babbage
30 Oct 2026
PARKD has secured two early-stage contracts, added Symal as its exclusive partner in Victoria and South Australia, and lifted pro forma cash to about A$850,000 through a strategic placement. The progress comes against a sharp liquidity squeeze, with just A$53,000 in cash at 30 September and funding equivalent to 0.21 quarters before the raise.
Victor Sage
Victor Sage
30 Oct 2026
Great Divide Mining increased Challenger concentrate production and plant feed rates during the September quarter, but ended with A$433,000 in cash and an estimated 0.9 quarters of funding. The company is relying on higher production, cost control or potential equity funding while advancing Coonambula towards a maiden resource estimate.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Hiremii’s revenue fell 11.1% to A$7.056 million in Q1 FY2027 as adjusted EBITDA slipped further into loss, testing the company’s transition towards AI-powered workforce intelligence. The new AQYR brand and two platform launches offer a growth narrative, but cash discipline remains central with A$1.789 million of total available funding.
Victor Sage
Victor Sage
30 Oct 2026
RMA Global delivered positive underlying EBITDA of A$0.12 million in the first quarter of FY27, despite weaker customer receipts and revenue. More than A$1.50 million in annualised costs has been removed, but cash of A$1.66 million leaves limited room for execution missteps.
Sophie Babbage
Sophie Babbage
29 Oct 2026
Bannerman Energy has cleared the two gates that mattered most for Etango: funding and Final Investment Decision. The Namibia uranium project now enters full-scale construction, with first production targeted for 2028 and construction cash largely in place.
Maxwell Dee
Maxwell Dee
29 Oct 2026
InFocus has reduced quarterly operating cash outflow by 40% while advancing Codexa and securing a conditional first customer for its overseas real-money gaming platform. The USD 2.4 million minimum fee commitment is substantial for the company, but it depends on development, licensing and launch milestones that have not yet been completed.
Sophie Babbage
Sophie Babbage
29 Oct 2026
Gratifii has put its rebuilt Connect+ Marketplace in front of Qantas, Woolworths MarketPlus and Blackhawk Network, opening distribution channels that reach millions of loyalty members. The commercial momentum came as quarterly cash receipts fell 16.5% and available funding stood at roughly 2.5 quarters.
Sophie Babbage
Sophie Babbage
29 Oct 2026
Comvita has moved from NZ$62.4 million of net debt to NZ$0.5 million of net cash in a year, while FY27 first-quarter sales rose 4.6%. The sharper test now is whether its operating reset can convert a stronger balance sheet into durable shareholder returns, with no FY27 dividend expected and board control still contested.
Victor Sage
Victor Sage
28 Oct 2026
EQ Resources has opened FY2027 with record revenue, EBITDA, profit and operating cashflow as tungsten production climbed 81% quarter-on-quarter. The company has also set its first full-year production, cost and capital expenditure targets, while expansion work and a Spanish regulatory issue remain key execution tests.
Maxwell Dee
Maxwell Dee
28 Oct 2026
Nova Eye Medical delivered 30% year-on-year sales growth in the September quarter, alongside positive operating cash flow and EBITDA. The company confirmed FY27 guidance, but is still seeking to replace a related-party funding facility carrying 15% interest.
Victor Sage
Victor Sage
27 Oct 2026

Browse the archive

Full archive